SCOTTSDALE, AZ / ACCESSWIRE / July 8, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL) through its wholly owned subsidiary, The CBD Vault Inc. a pioneering leader in the CBD industry, is excited to announce the launch of their new line of Delta 8 CBD Vape Cartridges. With the introduction of these premium cartridges, available in four tantalizing flavors-Bubba Kush, Watermelon Zkittles, Purple Punch, and Mimosa- CBDL is set to elevate the vaping experience for the customers while delivering unparalleled therapeutic benefits.
Product Highlights:
Delta 8: Each cartridge is infused with high-quality, Delta 8 CBD, ensuring the complete range of beneficial cannabinoids. This formulation maximizes the entourage effect, enhancing the therapeutic benefits and providing a superior vaping experience.
Delicious Flavors: available in four mouth-watering flavors: Bubba Kush, Watermelon Zkittles, Purple Punch, and Mimosa. These flavors not only delight the senses but also offer a unique vaping experience tailored to various preferences.
Premium Quality: CBD Vaults commitment to quality ensures that every cartridge is crafted with the highest standards, using only the finest ingredients and cutting-edge extraction methods.
Key Benefits:
Enhanced Therapeutic Effects: The Delta 8 in the cartridges provides comprehensive wellness benefits, including stress relief, pain management, and improved sleep quality.
Convenience and Discretion: CBDLs sleek and portable cartridges offer a convenient and discreet way to enjoy the benefits of CBD, making them perfect for use on the go.
Innovative Design: Designed for compatibility with standard vape pens, these cartridges ensure a smooth and enjoyable vaping experience.
Revenue and Growth Projections: President & CEO Lisa Nelson states, "Market research indicates a strong demand for high-quality CBD vape products, and we anticipate this new product line will drive significant revenue growth. We project a 50% increase in sales within the first six months of launch, bolstered by our robust marketing strategy and loyal customer base."
Investor Appeal:
Expanding Market: The global CBD market is projected to reach $13.4 billion by 2028, growing at a compound annual growth rate (CAGR) of 21.2% from 2021 to 2028. Vape products are among the fastest-growing segments, making CBDLs Delta 8 CBD vape cartridges a strategic entry point into this lucrative market.
Strategic Advantage: CBDLs focus on full-spectrum formulations and premium quality sets them apart from competitors, ensuring a strong market position and customer loyalty.
Sustainable Growth: With a strong pipeline of innovative products, the CBD Vault offers a compelling investment opportunity.
We invite investors to join CBDL on this exciting journey as the company continues to innovate and lead in the CBD industry. Together, we can achieve remarkable success and make a positive impact on the lives of our customers.
About The CBD Vault Inc.
The CBD Vault Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. The CBD Vault has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets. The CBD Vault's products can be viewed and purchased on the Company's website at www.thecbdvault.com
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
SOURCE: CBD Life Sciences Inc.
View the original press release on accesswire.com
